TY - JOUR
T1 - Protein-structure-guided discovery of functional mutations across 19 cancer types
AU - Niu, Beifang
AU - Scott, Adam D.
AU - Sengupta, Sohini
AU - Bailey, Matthew H.
AU - Batra, Prag
AU - Ning, Jie
AU - Wyczalkowski, Matthew A.
AU - Liang, Wen Wei
AU - Zhang, Qunyuan
AU - McLellan, Michael D.
AU - Sun, Sam Q.
AU - Tripathi, Piyush
AU - Lou, Carolyn
AU - Ye, Kai
AU - Jay Mashl, R.
AU - Wallis, John
AU - Wendl, Michael C.
AU - Chen, Feng
AU - Ding, Li
N1 - Publisher Copyright:
© 2016 Nature America, Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots (clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra- and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.
AB - Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots (clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra- and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.
UR - http://www.scopus.com/inward/record.url?scp=84980028158&partnerID=8YFLogxK
U2 - 10.1038/ng.3586
DO - 10.1038/ng.3586
M3 - Article
C2 - 27294619
AN - SCOPUS:84980028158
SN - 1061-4036
VL - 48
SP - 827
EP - 837
JO - Nature Genetics
JF - Nature Genetics
IS - 8
ER -